Cancer can be promoted by various signaling pathways, which are also activated in inflammation, such as transcription factors NF-κB, AP-1, STAT3, protein kinases such as MAPK or JNK, cell adhesion molecules such as ICAM, or COX-2 [67,68,95]. This evidence concerns the gene NFKB1 and cancer.